We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Blood-based Biomarkers Can Help To Predict Recurrence of Triple Negative Breast Cancer

News   Jul 10, 2020 | Original story from Indiana University School of Medicine

 
Blood-based Biomarkers Can Help To Predict Recurrence of Triple Negative Breast Cancer

This image shows a triple negative breast cancer cell undergoing retraction and apoptosis (cell death) after treatment with a combination of the chemotherapy drug cisplatin and a mitochondrial division inhibitor drug called mdivi-1. Credit: National Cancer Institute/University of Pittsburgh Cancer Institute. Creator: Wei Qian

 
 
Advertisement
 

RELATED ARTICLES

Super-Enhancers That Switch on Breast Cancer Genes Discovered

News

A research team has identified and characterized a set of specific super-enhancers that stimulate the activity of related critical cancer genes. The research has also discovered that the deletion of certain specific super-enhancers can reduce tumor cell growth.

READ MORE

Damage-Sensing Proteins Recognize DNA Breaks

News

Researchers have exploited cryogenic electron microscopy to visualize mechanisms behind DNA damage, by illuminating the mysterious cycle of DNA breakage sensing and repair.

READ MORE

Potential Drug Candidates for Difficult-To-Treat Pediatric Leukemia

News

Scientists have shown that two existing drug candidates hold potential as treatments for a deadly acute myeloid leukemia (AML) subtype that is more common in children.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE